Minerva Neurosciences (NERV) Share-based Compensation (2013 - 2026)

Minerva Neurosciences (NERV) has 13 years of Share-based Compensation data on file, last reported at $8.7 million in Q1 2026.

• Quarterly Share-based Compensation rose 2830.5% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (up 724.79% YoY) and the FY2025 annual result came in at $25.0 million, up 792.86% from the prior year.
• Share-based Compensation rose to $8.7 million in Q1 2026, from $459028.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $8.7 million in Q1 2026 to a low of $249650.0 in Q4 2024.
• A 5-year average of $1.1 million and a median of $459028.0 in 2025 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2023 — Share-based Compensation slumped 64.24% — and 2026, when it jumped 2830.5%.
• Tracing NERV's Share-based Compensation over 5 years: stood at $947684.0 in 2022, then plunged by 35.52% to $611064.0 in 2023, then plunged by 59.15% to $249650.0 in 2024, then soared by 83.87% to $459028.0 in 2025, then jumped by 1797.55% to $8.7 million in 2026.
• The last three Share-based Compensation figures came in at $8.7 million (Q1 2026), $459028.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.